ORMP icon

Oramed Pharmaceuticals

77 hedge funds and large institutions have $43.2M invested in Oramed Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+6
Holders Change %
+8.45%
% of All Funds
1.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
17
Reduced
17
Closed
12
Calls
$5.34M
Puts
$3.72M
Net Calls
+$1.62M
Net Calls Change
-$1.45M
Name Holding Trade Value Shares
Change
Shares
Change %
PAG
76
Private Advisor Group
New Jersey
$142 +$142 +11,794 New
BBHC
77
Brown Brothers Harriman & Co
New York
$96
Two Sigma Investments
78
Two Sigma Investments
New York
-$1.06M -163,015 Closed
EMG
79
ETF Managers Group
New Jersey
-$612K -94,493 Closed
Walleye Capital
80
Walleye Capital
New York
-$508K -78,418 Closed
Ameriprise
81
Ameriprise
Minnesota
-$256K -39,525 Closed
JF
82
Jump Financial
Illinois
-$234K -36,100 Closed
Commonwealth Equity Services
83
Commonwealth Equity Services
Massachusetts
-$194K -30,014 Closed
E
84
Ergoteles
New York
-$156K -24,149 Closed
VF
85
Virtu Financial
New York
-$139K -21,526 Closed
KCM
86
Knoll Capital Management
Florida
-$130K -20,000 Closed
BCV
87
Banque Cantonale Vaudoise
Switzerland
-$130K -20,000 Closed
SSA
88
Schonfeld Strategic Advisors
New York
-$106K -16,400 Closed
RJFSA
89
Raymond James Financial Services Advisors
Florida
-$67K -10,372 Closed